← All trials
NCT04302870
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 27, 2020
- Primary completion
- Sep 30, 2026
- Completion date
- Dec 31, 2026
- First posted
- Mar 10, 2020
- Last posted
- Mar 10, 2020
- Enrollment
- 750
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of EdinburghLead sponsor
- University of LondonCollaborator
- University of WarwickCollaborator
- University of EdinburghStudy director
- NHS LothianCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.